Zucero is an Australian-based biotechnology company focussed on the development of pixatimod, an immunotherapy for the treatment of cancer. Pixatimod successfully completed safety evaluation in a Phase 1a clinical trial. It is currently under investigation in a Phase 1b study in combination with Opdivo® (immune checkpoint inhibitor) for pancreatic cancer, and new investigations in colon cancer is now being planned.
View Top Employees from Zucero| Website | http://www.zucero.com.au |
| Revenue | $6 million |
| Employees | 4 (1 on RocketReach) |
| Founded | 2016 |
| Address | 1, 1 Westlink Ct, Darra, Queensland 4076, AU |
| Phone | +61 7 3067 2402 |
| Technologies |
JavaScript,
HTML,
Twitter
+9 more
(view full list)
|
| Industry | Business Services General, Business Services |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541714 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies |
Looking for a particular Zucero employee's phone or email?
Zucero Questions
The Zucero annual revenue was $6 million in 2024.
Paul Handley is the Head of Chemistry of Zucero.
1 people are employed at Zucero.
Zucero is based in Darra, Queensland.
The NAICS codes for Zucero are [541714, 54, 54171, 5417, 541].
The SIC codes for Zucero are [873, 87].
Top Zucero Employees
